BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16979838)

  • 1. Single-nucleotide polymorphisms in base excision repair, nucleotide excision repair, and double strand break genes as markers for response to radiotherapy in patients with Stage I to II head-and-neck cancer.
    Carles J; Monzo M; Amat M; Jansa S; Artells R; Navarro A; Foro P; Alameda F; Gayete A; Gel B; Miguel M; Albanell J; Fabregat X
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1022-30. PubMed ID: 16979838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
    Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
    Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA.
    Lu B; Li J; Gao Q; Yu W; Yang Q; Li X
    Gene; 2014 May; 542(1):64-8. PubMed ID: 24582975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck.
    Cheng L; Sturgis EM; Eicher SA; Spitz MR; Wei Q
    Cancer; 2002 Jan; 94(2):393-7. PubMed ID: 11900225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.
    Werbrouck J; De Ruyck K; Duprez F; Van Eijkeren M; Rietzschel E; Bekaert S; Vral A; De Neve W; Thierens H
    Mutat Res; 2008 Oct; 656(1-2):74-81. PubMed ID: 18768166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single nucleotide polymorphisms in nucleotide excision repair genes XPA, XPD, XPG and ERCC1 in advanced colorectal cancer patients treated with first-line oxaliplatin/fluoropyrimidine.
    Monzo M; Moreno I; Navarro A; Ibeas R; Artells R; Gel B; Martinez F; Moreno J; Hernandez R; Navarro-Vigo M
    Oncology; 2007; 72(5-6):364-70. PubMed ID: 18204222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.
    Gu J; Zhao H; Dinney CP; Zhu Y; Leibovici D; Bermejo CE; Grossman HB; Wu X
    Clin Cancer Res; 2005 Feb; 11(4):1408-15. PubMed ID: 15746040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
    Quintela-Fandino M; Hitt R; Medina PP; Gamarra S; Manso L; Cortes-Funes H; Sanchez-Cespedes M
    J Clin Oncol; 2006 Sep; 24(26):4333-9. PubMed ID: 16896002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candidate apoptotic and DNA repair gene approach confirms involvement of ERCC1, ERCC5, TP53 and MDM2 in radiation-induced toxicity in head and neck cancer.
    Borchiellini D; Etienne-Grimaldi MC; Bensadoun RJ; Benezery K; Dassonville O; Poissonnet G; Llorca L; Ebran N; Formento P; Château Y; Thariat J; Milano G
    Oral Oncol; 2017 Apr; 67():70-76. PubMed ID: 28351583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Polymorphisms of XPC, XPD, XPG Genes and their Association with Radiotherapy Induced Toxicity among Head and Neck Cancer Patients: A Hospital Based Study from Maharashtra.
    Gudur AK; Kale SR; Gudur RA; Bhosale SJ; Datkhile KD
    Asian Pac J Cancer Prev; 2024 Jan; 25(1):191-199. PubMed ID: 38285784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between single-nucleotide polymorphisms in DNA double-strand break repair genes and prostate cancer aggressiveness in the Spanish population.
    Henríquez-Hernández LA; Valenciano A; Foro-Arnalot P; Álvarez-Cubero MJ; Cozar JM; Suárez-Novo JF; Castells-Esteve M; Fernández-Gonzalo P; De-Paula-Carranza B; Ferrer M; Guedea F; Sancho-Pardo G; Craven-Bartle J; Ortiz-Gordillo MJ; Cabrera-Roldán P; Rodríguez-Melcón JI; Herrera-Ramos E; Rodríguez-Gallego C; Lara PC
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):28-34. PubMed ID: 26754263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer.
    Zienolddiny S; Campa D; Lind H; Ryberg D; Skaug V; Stangeland L; Phillips DH; Canzian F; Haugen A
    Carcinogenesis; 2006 Mar; 27(3):560-7. PubMed ID: 16195237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laryngeal cancer risk associated with smoking and alcohol consumption is modified by genetic polymorphisms in ERCC5, ERCC6 and RAD23B but not by polymorphisms in five other nucleotide excision repair genes.
    Abbasi R; Ramroth H; Becher H; Dietz A; Schmezer P; Popanda O
    Int J Cancer; 2009 Sep; 125(6):1431-9. PubMed ID: 19444904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk.
    Huang WY; Berndt SI; Kang D; Chatterjee N; Chanock SJ; Yeager M; Welch R; Bresalier RS; Weissfeld JL; Hayes RB
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):306-11. PubMed ID: 16492920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA repair gene polymorphisms and risk of head and neck cancer in the Tunisian population.
    Khlifi R; Kallel I; Hammami B; Hamza-Chaffai A; Rebai A
    J Oral Pathol Med; 2014 Mar; 43(3):217-24. PubMed ID: 24020925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.
    Sullivan I; Salazar J; Majem M; Pallarés C; Del Río E; Páez D; Baiget M; Barnadas A
    Cancer Lett; 2014 Oct; 353(2):160-6. PubMed ID: 25069034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck.
    An J; Liu Z; Hu Z; Li G; Wang LE; Sturgis EM; El-Naggar AK; Spitz MR; Wei Q
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1633-8. PubMed ID: 17684138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in nucleotide excision repair genes and endometrial cancer risk.
    Doherty JA; Weiss NS; Fish S; Fan W; Loomis MM; Sakoda LC; Rossing MA; Zhao LP; Chen C
    Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1873-82. PubMed ID: 21750170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of allelic Variations of hypoxia-related and DNA repair genes on patient outcome and toxicity in head and neck cancer treated with radiotherapy plus cetuximab.
    Muñoz C; Caballero M; Hakim S; Verger E; Grau JJ
    Eur Arch Otorhinolaryngol; 2016 Aug; 273(8):2193-9. PubMed ID: 26245169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival.
    Azad AK; Bairati I; Samson E; Cheng D; Mirshams M; Qiu X; Savas S; Waldron J; Wang C; Goldstein D; Xu W; Meyer F; Liu G
    Clin Cancer Res; 2012 Jan; 18(1):196-206. PubMed ID: 22076708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.